Hos ældre patienter (> 65 år) som modtog Avastin, var der ingen forhøjet incidens af Avastin - relaterede hændelser, inklusive gastrointestinal perforation, sårhelingskomplikationer, hypertension, proteinuri, kongestiv hjertesygdom og blødninger, sammenlignet med patienter under 65 år, som modtog Avastin.
No increase in the incidence of other reactions, including gastrointestinal perforation, wound healing complications, hypertension, proteinuria, congestive heart failure, and haemorrhage was observed in elderly patients (> 65 years) receiving Avastin as compared to those aged ≤ 65 years treated with Avastin.